1. Home
  2. GMM vs ICCC Comparison

GMM vs ICCC Comparison

Compare GMM & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

HOLD

Current Price

$1.28

Market Cap

38.4M

Sector

N/A

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$5.46

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMM
ICCC
Founded
2017
1982
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.4M
55.5M
IPO Year
2023
1987

Fundamental Metrics

Financial Performance
Metric
GMM
ICCC
Price
$1.28
$5.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.8K
19.4K
Earning Date
08-18-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.79
0.26
Revenue
$48,171,048.00
$27,769,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.71
$20.18
Revenue Growth
41.74
16.49
52 Week Low
$1.23
$4.28
52 Week High
$4.97
$7.60

Technical Indicators

Market Signals
Indicator
GMM
ICCC
Relative Strength Index (RSI) 30.01 55.08
Support Level $1.25 $4.72
Resistance Level $1.59 $5.36
Average True Range (ATR) 0.09 0.34
MACD -0.02 0.10
Stochastic Oscillator 28.21 100.00

Price Performance

Historical Comparison
GMM
ICCC

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: